Story perspectives

Danaher Beats Estimates, Raises Earnings Outlook, Cuts Growth Forecast

7/22/2026

Summary

Story summary

Danaher Corp. reported adjusted earnings of $1.94 per share, beating the analyst consensus estimate of $1.83.
Revenue rose 5.5% year over year to $6.27 billion, surpassing analysts’ expectation of $6.10 billion.
Life Sciences revenue increased 5.5% to $1.88 billion, with bioprocessing orders rising in the mid-teens.
Danaher lowered its fiscal 2026 core revenue growth outlook to 3%-4% and raised its adjusted earnings forecast to $8.45-$8.60 per share.

1 of 1

Story summary

Danaher Corp. reported adjusted earnings of $1.94 per share, beating the analyst consensus estimate of $1.83.
Revenue rose 5.5% year over year to $6.27 billion, surpassing analysts’ expectation of $6.10 billion.
Life Sciences revenue increased 5.5% to $1.88 billion, with bioprocessing orders rising in the mid-teens.
Danaher lowered its fiscal 2026 core revenue growth outlook to 3%-4% and raised its adjusted earnings forecast to $8.45-$8.60 per share.